ARTV

Artiva Biotherapeutics, Inc.$9.67+0.32 (+3.42%)

Prev Close$9.35·MCap$231.1M·P/E—·Vol284.4K·Yield—

▲

Buys (12M)

$104.24M

▼

Sells (12M)

$811.2K

◆

Net Activity

Net Buyer

$103.42M

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at Artiva Biotherapeutics, Inc. (ARTV) has been dominated by buying, with 6 insider purchases totaling $104.24M and 16 insider sales totaling $811.2K. The most recent insider transaction was by RA CAPITAL MANAGEMENT, L.P. (director, 10 percent owner: ), who purchased $194.0K worth of shares on Jul 14, 2026. Artiva Biotherapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $231.1M.

ARTV Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Jul 14, 2026	RA CAPITAL MANAGEMENT, L.P.	director, 10 percent owner:	Buy	21,654	$8.96	$194.0K	16,817,572
Jun 29, 2026	RA CAPITAL MANAGEMENT, L.P.	director, 10 percent owner:	Buy	32,876	$8.89	$292.1K	16,795,920
Jun 16, 2026	RA CAPITAL MANAGEMENT, L.P.	director, 10 percent owner:	Buy	531,326	$8.66	$4.60M2.1% OS	16,763,043
Jun 11, 2026	RA CAPITAL MANAGEMENT, L.P.	director, 10 percent owner:	Buy	1,027,722	$7.44	$7.65M4.2% OS	16,231,717
May 28, 2026	GC Corp.	10 percent owner	Buy	1,432,291	$11.52	$16.50M5.8% OS	4,391,969+48%
May 19, 2026	Raymon Heather	officer: SVP, Research and Development	Sell	3,095	$9.01	$27.9K	148,228
May 19, 2026	Aslan Fred	director, officer: Chief Executive Officer	Sell	27,116	$9.01	$244.3K	1,535,082
May 19, 2026	Banerjee Subhashis	officer: Chief Medical Officer	Sell	7,037	$9.01	$63.4K	144,963
May 19, 2026	Horan Christopher	officer: Chief Tech Operations Officer	Sell	7,002	$9.01	$63.1K	293,450
May 19, 2026	Bush Jennifer	officer: COO, CLO, Compliance Officer	Sell	8,790	$9.01	$79.2K	337,920
May 13, 2026	RA CAPITAL MANAGEMENT, L.P.	director, 10 percent owner:	Buy	6,510,416	$11.52	$75.00M26.3% OS	15,203,995+75%
Feb 15, 2026	Aslan Fred	President and CEO	Sell	14,600	$4.00	$58.4K	0
Feb 15, 2026	Bush Jennifer	COO, CLO, Secy, Compliance Off	Sell	3,515	$4.00	$14.1K	0
Feb 15, 2026	Horan Christopher	Chief Tech Operations Officer	Sell	2,187	$4.00	$8.7K	0
Feb 15, 2026	Raymon Heather	SVP, Research and Development	Sell	1,521	$4.00	$6.1K	0
Dec 15, 2025	Aslan Fred	President and CEO	Sell	3,187	$6.00	$19.1K	0
Nov 15, 2025	Aslan Fred	President and CEO	Sell	12,722	$3.31	$42.1K	0
Nov 15, 2025	Bush Jennifer	COO, CLO, Secy, Compliance Off	Sell	3,055	$3.25	$9.9K	0
Nov 15, 2025	Horan Christopher	Chief Tech Operations Officer	Sell	1,899	$3.25	$6.2K	0
Nov 15, 2025	Krishnamohan Neha	Chief Financial Officer	Sell	3,490	$3.25	$11.3K	0
Nov 15, 2025	Raymon Heather	SVP, Research and Development	Sell	1,375	$3.25	$4.5K	0
Oct 17, 2025	Aslan Fred	President and CEO	Sell	25,500	$6.00	$153.0K	0
May 15, 2025	Aslan Fred	President and CEO	Sell	34,444	$2.65	$91.4K	0
May 15, 2025	Bush Jennifer	COO, CLO, Secy, Compliance Off	Sell	8,346	$2.61	$21.8K	0
May 15, 2025	Horan Christopher	Chief Tech Operations Officer	Sell	3,577	$2.75	$9.8K	0
May 15, 2025	Krishnamohan Neha	Chief Financial Officer	Sell	7,154	$2.63	$18.8K	0
May 15, 2025	Raymon Heather	SVP, Research and Development	Sell	2,384	$2.56	$6.1K	0
Jul 22, 2024	Huh Yong-Jun	Director	Buy	2,083,332	$12.00	$25.00M8.4% OS	0

ARTV Insider Buying Activity

The following table shows recent insider purchases of Artiva Biotherapeutics, Inc. (ARTV) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Jul 14, 2026	RA CAPITAL MANAGEMENT, L.P.	director, 10 percent owner:	Buy	21,654	$8.96	$194.0K	16,817,572
Jun 29, 2026	RA CAPITAL MANAGEMENT, L.P.	director, 10 percent owner:	Buy	32,876	$8.89	$292.1K	16,795,920
Jun 16, 2026	RA CAPITAL MANAGEMENT, L.P.	director, 10 percent owner:	Buy	531,326	$8.66	$4.60M2.1% OS	16,763,043
Jun 11, 2026	RA CAPITAL MANAGEMENT, L.P.	director, 10 percent owner:	Buy	1,027,722	$7.44	$7.65M4.2% OS	16,231,717
May 28, 2026	GC Corp.	10 percent owner	Buy	1,432,291	$11.52	$16.50M5.8% OS	4,391,969+48%
May 13, 2026	RA CAPITAL MANAGEMENT, L.P.	director, 10 percent owner:	Buy	6,510,416	$11.52	$75.00M26.3% OS	15,203,995+75%
Jul 22, 2024	Huh Yong-Jun	Director	Buy	2,083,332	$12.00	$25.00M8.4% OS	0

ARTV Insider Selling Activity

The following table shows recent insider sales of Artiva Biotherapeutics, Inc. (ARTV) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
May 19, 2026	Raymon Heather	officer: SVP, Research and Development	Sell	3,095	$9.01	$27.9K	148,228
May 19, 2026	Aslan Fred	director, officer: Chief Executive Officer	Sell	27,116	$9.01	$244.3K	1,535,082
May 19, 2026	Banerjee Subhashis	officer: Chief Medical Officer	Sell	7,037	$9.01	$63.4K	144,963
May 19, 2026	Horan Christopher	officer: Chief Tech Operations Officer	Sell	7,002	$9.01	$63.1K	293,450
May 19, 2026	Bush Jennifer	officer: COO, CLO, Compliance Officer	Sell	8,790	$9.01	$79.2K	337,920
Feb 15, 2026	Aslan Fred	President and CEO	Sell	14,600	$4.00	$58.4K	0
Feb 15, 2026	Bush Jennifer	COO, CLO, Secy, Compliance Off	Sell	3,515	$4.00	$14.1K	0
Feb 15, 2026	Horan Christopher	Chief Tech Operations Officer	Sell	2,187	$4.00	$8.7K	0
Feb 15, 2026	Raymon Heather	SVP, Research and Development	Sell	1,521	$4.00	$6.1K	0
Dec 15, 2025	Aslan Fred	President and CEO	Sell	3,187	$6.00	$19.1K	0
Nov 15, 2025	Aslan Fred	President and CEO	Sell	12,722	$3.31	$42.1K	0
Nov 15, 2025	Bush Jennifer	COO, CLO, Secy, Compliance Off	Sell	3,055	$3.25	$9.9K	0
Nov 15, 2025	Horan Christopher	Chief Tech Operations Officer	Sell	1,899	$3.25	$6.2K	0
Nov 15, 2025	Krishnamohan Neha	Chief Financial Officer	Sell	3,490	$3.25	$11.3K	0
Nov 15, 2025	Raymon Heather	SVP, Research and Development	Sell	1,375	$3.25	$4.5K	0
Oct 17, 2025	Aslan Fred	President and CEO	Sell	25,500	$6.00	$153.0K	0
May 15, 2025	Aslan Fred	President and CEO	Sell	34,444	$2.65	$91.4K	0
May 15, 2025	Bush Jennifer	COO, CLO, Secy, Compliance Off	Sell	8,346	$2.61	$21.8K	0
May 15, 2025	Horan Christopher	Chief Tech Operations Officer	Sell	3,577	$2.75	$9.8K	0
May 15, 2025	Krishnamohan Neha	Chief Financial Officer	Sell	7,154	$2.63	$18.8K	0
May 15, 2025	Raymon Heather	SVP, Research and Development	Sell	2,384	$2.56	$6.1K	0